By Vanda Svobodova
Apple is fighting to overturn a U.S. import ban on some Apple Watch models due to a legal dispute with Masimo Corporation over blood oxygen sensor technology. The ban, issued after the International Trade Commission found Apple had infringed on Masimo’s patents, impacts key health-monitoring features central to Apple’s wearable strategy. As the tech giant pushes back, the case underscores growing tensions between innovation and intellectual property in the health tech space. The outcome could reshape the future of smartwatches and consumer health tech鈥攔aising the stakes not just for Apple, but for the entire industry.